Trial Profile
Tiotropium bromide +/- tulobuterol in patients with chronic obstructive pulmonary disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2010
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary) ; Tulobuterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 08 Nov 2010 New trial record
- 22 Sep 2010 Results presented at the 20th Annual Congress of the European Respiratory Society.